BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.85% |
| 2 | Financials | 5.5% |
| 3 | Healthcare | 5.05% |
| 4 | Consumer Discretionary | 4.67% |
| 5 | Industrials | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
2076
DELISTED
Clovis Oncology, Inc.
CLVS
| $782K | ﹤0.01% |
74,980
+4,019
| +6% | +$29.2K |
|
2077
National Health Investors
NHI
$3.59B
| $781K | ﹤0.01% |
9,582
-2,705
| -22% | -$221K |
|
|
CNXM
2078
DELISTED
CNX Midstream Partners LP
CNXM
| $779K | ﹤0.01% |
47,312
+5,794
| +14% | +$83.3K |
|
2079
UFP Industries
UFPI
$4.99B
| $778K | ﹤0.01% |
16,320
+5,146
| +46% | +$243K |
|
|
UFS
2080
DELISTED
DOMTAR CORPORATION (New)
UFS
| $776K | ﹤0.01% |
20,284
+4,237
| +26% | +$157K |
|
2081
Blackbaud
BLKB
$2.07B
| $775K | ﹤0.01% |
9,730
+13
| +0.1% | +$1.09K |
|
|
GWPH
2082
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $774K | ﹤0.01% |
7,407
+4,028
| +119% | +$452K |
|
2083
Applied Industrial Technologies
AIT
$13.4B
| $773K | ﹤0.01% |
11,584
+4,541
| +64% | +$279K |
|
2084
CALL
First Solar
FSLR
$24.2B
| $772K | ﹤0.01% |
138
| – | – |
|
2085
CALL
Lennar Class A
LEN
$20.9B
| $770K | ﹤0.01% |
+143
| New | +$8.16K |
|
2086
Old National Bancorp
ONB
$10.4B
| $767K | ﹤0.01% |
41,957
+11,024
| +36% | +$198K |
|
2087
Pinnacle Financial Partners Inc
PNFP
$16.3B
| $766K | ﹤0.01% |
11,963
-5,502
| -32% | -$332K |
|
2088
WD-40
WDFC
$3.08B
| $765K | ﹤0.01% |
3,941
+1,432
| +57% | +$270K |
|
2089
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $765K | ﹤0.01% |
14,385
+2,871
| +25% | +$153K |
|
2090
KB Home
KBH
$3.44B
| $765K | ﹤0.01% |
22,316
+5,582
| +33% | +$193K |
|
2091
Plains All American Pipeline
PAA
$16.8B
| $763K | ﹤0.01% |
41,517
-28,706
| -41% | -$527K |
|
2092
AXIS Capital
AXS
$7.4B
| $762K | ﹤0.01% |
12,828
-2,124
| -14% | -$128K |
|
2093
Americold
COLD
$4.25B
| $762K | ﹤0.01% |
21,748
-56,498
| -72% | -$2.08M |
|
2094
Innospec
IOSP
$2.31B
| $762K | ﹤0.01% |
7,371
+2,900
| +65% | +$277K |
|
2095
Fabrinet
FN
$20.4B
| $762K | ﹤0.01% |
11,758
+3,753
| +47% | +$217K |
|
|
TMHC
2096
DELISTED
Taylor Morrison
TMHC
| $761K | ﹤0.01% |
34,828
+5,058
| +17% | +$122K |
|
2097
Laureate Education
LAUR
$5.16B
| $760K | ﹤0.01% |
43,170
+13,898
| +47% | +$229K |
|
2098
NBT Bancorp
NBTB
$2.78B
| $760K | ﹤0.01% |
18,743
+9,959
| +113% | +$390K |
|
2099
LCI Industries
LCII
$2.56B
| $760K | ﹤0.01% |
7,090
+2,643
| +59% | +$268K |
|
2100
Patterson-UTI
PTEN
$4.34B
| $757K | ﹤0.01% |
72,051
-415,515
| -85% | -$3.76M |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.